A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period
Clinical trial NCT01264094 · TERMINATED
Trial details
- NCT number
- NCT01264094
- Sponsor
- Bukwang Pharmaceutical
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2014-11-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.